These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10619630)

  • 1. Beta-estradiol attenuate amyloid beta-peptide toxicity via nicotinic receptors.
    Svensson AL; Nordberg A
    Neuroreport; 1999 Nov; 10(17):3485-9. PubMed ID: 10619630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists.
    Jonnala RR; Buccafusco JJ
    J Neurosci Res; 2001 Nov; 66(4):565-72. PubMed ID: 11746376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of chronic drug treatment on alpha3* and alpha7 nicotinic receptor binding sites, in hippocampal neurones and SH-SY5Y cells.
    Ridley DL; Rogers A; Wonnacott S
    Br J Pharmacol; 2001 Aug; 133(8):1286-95. PubMed ID: 11498514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel nicotinic mechanism underlies β-amyloid-induced neurotoxicity.
    Liu Q; Xie X; Emadi S; Sierks MR; Wu J
    Neuropharmacology; 2015 Oct; 97():457-63. PubMed ID: 25959067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrine and donepezil attenuate the neurotoxic effect of A beta(25-35) in rat PC12 cells.
    Svensson AL; Nordberg A
    Neuroreport; 1998 May; 9(7):1519-22. PubMed ID: 9631459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity.
    Kihara T; Shimohama S; Sawada H; Kimura J; Kume T; Kochiyama H; Maeda T; Akaike A
    Ann Neurol; 1997 Aug; 42(2):159-63. PubMed ID: 9266724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
    Riganti L; Matteoni C; Di Angelantonio S; Nistri A; Gaimarri A; Sparatore F; Canu-Boido C; Clementi F; Gotti C
    Br J Pharmacol; 2005 Dec; 146(8):1096-109. PubMed ID: 16273122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cotinine binding to nicotinic acetylcholine receptors in bovine chromaffin cell and rat brain membranes.
    Vainio PJ; Tuominen RK
    Nicotine Tob Res; 2001 May; 3(2):177-82. PubMed ID: 11403732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors.
    Arias E; Gallego-Sandín S; Villarroya M; García AG; López MG
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1346-53. PubMed ID: 16144975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time and brain region specific up-regulation of low affinity neuronal nicotinic receptors during chronic nicotine administration in mice.
    Nuutinen S; Ahtee L; Tuominen RK
    Eur J Pharmacol; 2005 May; 515(1-3):83-9. PubMed ID: 15894304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alpha7 nicotinic acetylcholine receptor-selective antagonist, methyllycaconitine, partially protects against beta-amyloid1-42 toxicity in primary neuron-enriched cultures.
    Martin SE; de Fiebre NE; de Fiebre CM
    Brain Res; 2004 Oct; 1022(1-2):254-6. PubMed ID: 15353238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinic acetylcholine receptor antagonists alter the function and expression of serine racemase in PC-12 and 1321N1 cells.
    Singh NS; Paul RK; Ramamoorthy A; Torjman MC; Moaddel R; Bernier M; Wainer IW
    Cell Signal; 2013 Dec; 25(12):2634-45. PubMed ID: 24012499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of donepezil treatment on rat nicotinic acetylcholine receptor levels in vivo and in vitro.
    Reid RT; Sabbagh MN
    J Alzheimers Dis; 2003 Dec; 5(6):429-36. PubMed ID: 14757932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotinic receptor agonists and antagonists increase sAPPalpha secretion and decrease Abeta levels in vitro.
    Mousavi M; Hellström-Lindahl E
    Neurochem Int; 2009; 54(3-4):237-44. PubMed ID: 19111588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mecamylamine prevents tolerance but enhances whole brain [3H]epibatidine binding in response to repeated nicotine administration in rats.
    McCallum SE; Caggiula AR; Booth S; Breese CR; Lee MJ; Donny EC; Leonard S; Sved AF
    Psychopharmacology (Berl); 2000 May; 150(1):1-8. PubMed ID: 10867970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of donepezil through inhibition of GSK-3 activity in amyloid-beta-induced neuronal cell death.
    Noh MY; Koh SH; Kim Y; Kim HY; Cho GW; Kim SH
    J Neurochem; 2009 Mar; 108(5):1116-25. PubMed ID: 19077054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic ethanol treatment decreases [3H]epibatidine and [3H]nicotine binding and differentially regulates mRNA levels of nicotinic acetylcholine receptor subunits expressed in M10 and SH-SY5Y neuroblastoma cells.
    Gorbounova O; Svensson AL; Jönsson P; Mousavi M; Miao H; Hellström-Lindahl E; Nordberg A
    J Neurochem; 1998 Mar; 70(3):1134-42. PubMed ID: 9489734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epibatidine binding sites and activity in the spinal cord.
    Khan IM; Yaksh TL; Taylor P
    Brain Res; 1997 Apr; 753(2):269-82. PubMed ID: 9125412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha7 Nicotinic receptor gene delivery into mouse hippocampal neurons leads to functional receptor expression, improved spatial memory-related performance, and tau hyperphosphorylation.
    Ren K; Thinschmidt J; Liu J; Ai L; Papke RL; King MA; Hughes JA; Meyer EM
    Neuroscience; 2007 Mar; 145(1):314-22. PubMed ID: 17218065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of amyloid peptides on the increase in TrkA receptor expression induced by nicotine in vitro and in vivo.
    Li XD; Arias E; Jonnala RR; Mruthinti S; Buccafusco JJ
    J Mol Neurosci; 2005; 27(3):325-36. PubMed ID: 16280603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.